🔴 Rocket Pharmaceuticals is trading 5.23% down today after hotter-than-expected producer-inflation data

Rocket Pharmaceuticals is trading 5.23% down at $3.44 after broader market selling following hotter-than-expected producer-inflation data.

• The S&P 500, Nasdaq Composite, and Dow Jones Industrial Average are each down more than 0.5%, pressuring rate-sensitive growth stocks as investors reassess Federal Reserve rate-cut expectations.
• Rocket Pharmaceuticals is scheduled to participate in the Cantor Global Healthcare Conference on September 10, 2026; its investor-relations release reports no new company-specific disclosure or direct connection to the decline.
• Event ID: 6aa2b94d098edf0569c721c8